Jamshedpur Reporter

Pericarditis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032) | Key Companies – Leo Pharmaceuticals, Cogent Biosciences, Novartis Pharmaceuticals

 Breaking News
  • No posts were found

Pericarditis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032) | Key Companies – Leo Pharmaceuticals, Cogent Biosciences, Novartis Pharmaceuticals

May 24
16:55 2023
Pericarditis Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-2032) | Key Companies - Leo Pharmaceuticals, Cogent Biosciences, Novartis Pharmaceuticals
DelveInsight Business Research LLP
DelveInsight’s “Pericarditis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Pericarditis, historical and forecasted epidemiology as well as the Pericarditis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Pericarditis Overview

Pericarditis is inflammation of the pericardium, a sac-like structure with two thin layers of tissue that surround the heart to hold it in place and help it work. A small amount of fluid keeps the layers separate so there’s less friction between them as the heart beats.

The cause of pericarditis is often unknown, though viral infections are a common reason. Pericarditis may occur after a respiratory or digestive system infection. Chronic and recurring pericarditis may be caused by autoimmune disorders such as lupus, scleroderma and rheumatoid arthritis.

 Pericarditis Epidemiology Insights

  • The incidence of acute pericarditis is approximately 27.7 per 100,000 individuals annually. The recurrence of the disease is seen in almost 30% of patients after the first episode. The mortality rate of acute pericarditis is approximately 1.1% in developed countries.

  • It mostly affects men ages 20 to 50 years. Pericarditis is often the result of an infection such as Viral infection that causes a chest cold or pneumonia. Infections with bacteria (less common)

 

Click here to learn more about the Pericarditis Market Landscape

The Report Covers the Pericarditis Epidemiology Segmented by:

  • Total Pericarditis incident cases 

  • Total Pericarditis prevalent cases 

  • Total Pericarditis treatment cases 

  • Total Pericarditis diagnostic cases 

Pericarditis Market Outlook 

Key Companies Working in the Pericarditis Market

  • Leo Pharmaceuticals 

  • Cogent Biosciences 

  • Novartis Pharmaceuticals 

  • GT Biopharmaceuticals Inc 

  • FSD Pharmaceuticals Inc

And many others 

Pericarditis Therapies Covered and Analyzed in the Report:

  • Masitinib

  • Cromoglicate

  • TF002

  • Avapritinib

  • PA101

And many others 

Learn more about the Key Companies and Emerging Therapies in the Pericarditis Market

 Table of Contents 

  1. Key Insights 

  2. Pericarditis Introduction 

  3. Executive Summary of Pericarditis     

  4. Disease Background and Overview

  5. Epidemiology and patient population

  6. Pericarditis Emerging Therapies

  7. Pericarditis Market Outlook

  8. Market Access and Reimbursement of Therapies

  9. Market Drivers 

  10. Market Barriers 

  11. Appendix

  12. Report Methodology

  13. DelveInsight Capabilities

  14. Disclaimer

Learn about the detailed offerings of the report @ Pericarditis Market Outlook 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Recent Posts

Advanced Melanoma Pipeline Outlook Report 2024 | Clinical Trials, FDA, EMA, PMDA Approvals, Drugs and Companies

Read Full Article

Categories